A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
Sites in Hackensack +4 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT05372354·Phase 1, Phase 2·Recruiting·Listed May 2022